Communication
Dalton Transactions
immunoblot analysis. As shown in Fig. 3, the reduction of the
HIF-1α protein expression by probe 7 was similar to that by 1a
and 1d.
8 G. L. Semenza, Nat. Rev. Cancer, 2003, 3, 721–732.
9 G. Dachs, A. Steele, C. Coralli, C. Kanthou, A. Brooks,
S. Gunningham, M. Currie, A. Watson, B. Robinson and
G. Tozer, BMC Cancer, 2006, 6, 280.
We next performed photo-affinity labeling in HeLa cells and
click conjugation with azide-linked biotin for the pull-down 10 A. F. Armstrong and J. F. Valliant, Dalton Trans., 2007,
assay. As shown in Fig. 4, proteins conjugated to multifunc- 4240–4251.
tional probe molecule 7 were separated by SDS-PAGE and pro- 11 M. Scholz and E. Hey-Hawkins, Chem. Rev., 2011, 111,
teins bound to molecule 7 were stained with Coomassie blue. 7035–7062.
Among the proteins, the major band appearing around 50 kDa 12 D.-H. Wu, C.-H. Wu, Y.-Z. Li, D.-D. Guo, X.-M. Wang and
was identified as tubulin (lane 3) by ESI-LC-MS analysis. H. Yan, Dalton Trans., 2009, 285–290.
Furthermore, immunoblot analysis revealed that tubulin was 13 G. Zhang, C. Wu, H. Ye, H. Yan and X. Wang, J. Nanobio-
bound to 7 (lane 4). These results indicate that tubulin is one
of the target proteins of compounds 1a and 1d.
technol., 2011, 9, 6.
14 N. P. E. Barry and P. J. Sadler, Chem. Soc. Rev., 2012, 41,
3264–3279.
15 V. I. Bregadze, Chem. Rev., 1992, 92, 209–223.
16 Y. Endo, T. Iijima, Y. Yamakoshi, H. Fukasawa, C. Miyaura,
M. Inada, A. Kubo and A. Itai, Chem. Biol., 2001, 8, 341–
355.
Conclusions
We succeeded in the synthesis of diaryl-substituted ortho-
carboranes 1a–g as analogs of CA-4 by coupling decaborane
with alkynes 3a–g in good yields. Microwave irradiation was 17 S. Fujii, H. Masuno, Y. Taoda, A. Kano, A. Wongmayura,
effective for the coupling in the presence of N,N-dimethylani-
line as the Lewis base in chlorobenzene. Significant inhibition
of the hypoxia-induced HIF-1 transcriptional activity was
M. Nakabayashi, N. Ito, M. Shimizu, E. Kawachi, T. Hirano,
Y. Endo, A. Tanatani and H. Kagechika, J. Am. Chem. Soc.,
2011, 133, 20933–20941.
observed in all the synthesized diaryl-substituted ortho-carbor- 18 H. S. Ban, K. Shimizu, H. Minegishi and H. Nakamura,
ane analogs 1a–g with IC50 values between 0.6 and 6.4 µM. In J. Am. Chem. Soc., 2010, 132, 11870–11871.
particular, compounds 1a and 1d had high potency: both 19 H. S. Ban, H. Minegishi, K. Shimizu, M. Maruyama,
compounds similarly suppressed the hypoxia-induced HIF-1α
Y. Yasui and H. Nakamura, ChemMedChem, 2010, 5, 1236–
accumulation in a concentration-dependent manner without
1241.
affecting HIF-1α mRNA expression. The pull-down assay using 20 H. S. Ban, K. Shimizu, H. Minegishi and H. Nakamura,
multifunctional probe molecule 7 revealed that tubulin is one Pure Appl. Chem., 2012, 84, 13.
of the target proteins of diaryl-substituted ortho-carborane 21 H. Minegishi, T. Matsukawa and H. Nakamura, ChemMed-
analogs 1, indicating that the suppression mechanism of 1 Chem, 2013, 8, 265–271.
toward the hypoxia-induced HIF-1α accumulation is similar to 22 N. J. Lawrence, F. A. Ghani, L. A. Hepworth, J. A. Hadfield,
that of CA-4.
A. T. McGown and R. G. Pritchard, Synthesis, 1999, 1656–
1660.
23 W. E. Hill, F. A. Johnson and R. W. Novak, Inorg. Chem.,
1975, 14, 1244–1249.
Notes and references
1 A. Jordan, J. A. Hadfield, N. J. Lawrence and A. T. McGown, 24 H. Nagasawa et al., Unpublished results.
Med. Res. Rev., 1998, 18, 259–296.
25 H. Minegishi, S. Fukashiro, H. S. Ban and H. Nakamura,
2 C. Dumontet and M. A. Jordan, Nat. Rev. Drug Discovery,
2010, 9, 790–803.
3 A. Dowlati, K. Robertson, M. Cooney, W. P. Petros,
M. Stratford, J. Jesberger, N. Rafie, B. Overmoyer,
ACS Med. Chem. Lett., 2013, 4, 297–301.
26 Y.-S. Chun, E.-J. Yeo, E. Choi, C.-M. Teng, J.-M. Bae,
M.-S. Kim and J.-W. Park, Biochem. Pharmacol., 2001, 61,
947–954.
V. Makkar, B. Stambler, A. Taylor, J. Waas, J. S. Lewin, 27 A. Takeuchi, M. Hori, S. Sato, H. S. Ban, T. Kuchimaru,
K. R. McCrae and S. C. Remick, Cancer Res., 2002, 62,
3408–3416.
S. Kizaka-Kondoh, T. Yamori and H. Nakamura, MedChem-
Comm, 2012, 3, 1455–1461.
4 G. J. M. Zweifel, N. Reed, R. Osborne, B. Hassan, 28 F. Kotzyba-Hibert, I. Kapfer and M. Goeldner, Angew.
G. Shreeves, L. Poupard, P. A. Walicke, J. Balkissoon,
D. Chaplin and G. Rustin, J. Clin. Oncol., 2009, 27, 1.
5 N. Ferrara, H. P. Gerber and J. LeCouter, Nat. Med., 2003, 9,
669–676.
6 N. Ferrara and R. S. Kerbel, Nature, 2005, 438, 967–974.
7 J. Folkman, Nat. Rev. Drug Discovery, 2007, 6, 273–286.
Chem., Int. Ed. Engl., 1995, 34, 1296.
29 H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem.,
Int. Ed., 2001, 40, 2004–2021.
30 V. V. Rostovtsev, L. G. Green, V. V. Fokin and
K. B. Sharpless, Angew. Chem., Int. Ed., 2002, 41, 2596–
2599.
Dalton Trans.
This journal is © The Royal Society of Chemistry 2014